- Inicio
- Análisis de app
- AnticoagEvaluator
- AnticoagEvaluator Vs. MAQI2 Anticoagulation Toolkit
AnticoagEvaluator vs MAQI2 Anticoagulation Toolkit Uso & Estadísticas
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
AnticoagEvaluator frente a MAQI2 Anticoagulation Toolkit: comparación de la clasificación
Comparar la tendencia de clasificación de AnticoagEvaluator en los últimos 28 días con MAQI2 Anticoagulation Toolkit
Rank
No hay datos disponibles
Comparación de las clasificaciones AnticoagEvaluator frente a MAQI2 Anticoagulation Toolkit por países
Comparar la tendencia de clasificación de AnticoagEvaluator en los últimos 28 días con MAQI2 Anticoagulation Toolkit
No hay datos para mostrar
Compara con cualquier sitio gracias a nuestra prueba gratuita
AnticoagEvaluator VS.
MAQI2 Anticoagulation Toolkit
19iciembre d, 2024